Trade Bristol Myers ^BMY

Cadence Bank Increases Stock Holdings in Bristol Myers Squibb Company $BMY

Eliquis Outperforms Xarelto in Safety for Treating Deep Blood Clots, ETPharma

Bristol Myers Squibb Company $BMY Shares Purchased by Te Ahumairangi Investment Management Ltd - Stock Observer

Opdualag (Bristol-Myers Squibb) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Bristol Myers Squibb Company $BMY Shares Sold by Martingale Asset Management L P

143,691 Shares in Bristol Myers Squibb Company $BMY Acquired by Entropy Technologies LP

Martingale Asset Management L P Has $21.75 Million Holdings in Bristol Myers Squibb Company $BMY - Stock Observer

Bokf Na Boosts Stake in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Sold by Employees Retirement System of Texas - Stock Observer

Quadrature Capital Ltd Purchases Shares of 532,436 Bristol Myers Squibb Company $BMY - Daily Political

Mackenzie Financial Corp Acquires 149,701 Shares of Bristol Myers Squibb Company $BMY - Daily Political

A Look At Bristol Myers Squibb (BMY) Valuation After Recent Share Price Volatility

Merck's WELIREG Kidney Cancer Trials Deepen Oncology Growth Story

Radioligand Therapies Market Set for Significant Growth by 2034, Driven by Rising Cancer Burden and Targeted Radiopharmaceutical Innovation | DelveInsight

Bristol Myers Squibb Company $BMY Shares Purchased by Franklin Resources Inc. - Stock Observer

Piper Sandler Sees Path to Growth for Bristol-Myers Squibb Company (BMY) After Eliquis Patent Expiry

How Investors May Respond To Bristol Myers (BMY) Mezigdomide Successor-2 Data And New Sotyktu Approval

Richard Bernstein Advisors LLC Lowers Position in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Sold by Capital Group Private Client Services Inc.

How big business is rewriting the U.S. sustainability story

BioNTech Founders to Leave Company by 2026 for New mRNA Venture, ETPharma

UBS Boosts Bristol-Myers Squibb (BMY) Price Target as Milvexian Data Looms

LGT Fund Management Co Ltd. Has $372,000 Stock Position in Bristol Myers Squibb Company $BMY

Abecma (Bristol-Myers Squibb) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

Bristol Myers Squibb Pipeline Update With New TYK2 And CELMoD Milestones

Bristol-Myers Squibb Readies New Growth Drivers In Immunology And Cancer

Banque Cantonale Vaudoise Acquires 26,347 Shares of Bristol Myers Squibb Company $BMY

Van ECK Associates Corp Acquires 3,982,439 Shares of Bristol Myers Squibb Company $BMY - Daily Political

LGT Fund Management Co Ltd. Has $372,000 Holdings in Bristol Myers Squibb Company $BMY - Daily Political

Advances in the management of metastatic gastric cancer: current strategies and emerging therapeutics

B cell depletion in autoimmune disease: in vivo CAR-T or T cell engagers?

Health: Bristol's drug enhances survival rates in late-stage blood cancer trial

Neuroendocrine Carcinoma Market Poised for Significant Growth During the Forecast Period (2026-2036) Driven by Rising Incidence and Advancements in Targeted Therapies | DelveInsight

Swiss National Bank Has $264.57 Million Stake in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Sold by Korea Investment CORP

Schroder Investment Management Group Has $548.82 Million Stake in Bristol Myers Squibb Company $BMY - Stock Observer

Blair William & Co. IL Lowers Holdings in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company (NYSE:BMY) Receives Consensus Rating of "Hold" from Brokerages

Why Bristol Myers Squibb Stock Crushed it in February

Bristol Myers announces U.S. FDA approved Sotyktu for treatment of PsA | Markets Insider

Bristol Myers Squibb Company $BMY Shares Acquired by Vinva Investment Management Ltd

Bristol Myers Squibb Company $BMY Shares Purchased by First Trust Advisors LP - Stock Observer

RAS/BRAF wild-type metastatic high-methylated colorectal cancer has gene expression patterns related to MSI-H and BRAF V600E mutant: a translational research

Trustmark Bank Trust Department Has $1.68 Million Holdings in Bristol Myers Squibb Company $BMY - Stock Observer

Significantly more patients treated with once-daily, oral So

IFG Advisory LLC Buys New Shares in Bristol Myers Squibb Company $BMY - Markets Daily

IFG Advisory LLC Acquires New Position in Bristol Myers Squibb Company $BMY - Stock Observer

Is It Too Late To Consider Bristol Myers Squibb (BMY) After Recent Share Price Strength?

Stonebridge Capital Advisors LLC Has $7.97 Million Holdings in Bristol Myers Squibb Company $BMY

Q4 Earnings Outperformers: Bristol-Myers Squibb (NYSE:BMY) And The Rest Of The Branded Pharmaceuticals Stocks

Assessing Bristol Myers Squibb (BMY) Valuation After Recent Share Price Momentum And 2024 Results

BeOne Medicines Pharma Alliances Contrast With High P/E And Valuation Upside

Bristol Myers Squibb Company $BMY Shares Purchased by Victory Capital Management Inc.

Victory Capital Management Inc. Grows Stock Holdings in Bristol Myers Squibb Company $BMY - Stock Observer

How New Oncology Wins and a Fresh Dividend At Bristol Myers Squibb (BMY) Have Changed Its Investment Story

Kahn Brothers Group Inc. Sells 278,349 Shares of Bristol Myers Squibb Company $BMY

American Century Companies Inc. Cuts Position in Bristol Myers Squibb Company $BMY

Kahn Brothers Group Inc. Has $12.28 Million Position in Bristol Myers Squibb Company $BMY - Daily Political

Laurel Wealth Advisors LLC Has $322,000 Position in Bristol Myers Squibb Company $BMY - Daily Political

Acute Ischemic Stroke Market Poised for Expansion During the Forecast Period (2026-2036) as Innovative Treatment Modalities Gain Momentum | DelveInsight

Round Hill Asset Management Purchases 24,934 Shares of Bristol Myers Squibb Company $BMY - Markets Daily

Round Hill Asset Management Has $3.19 Million Stake in Bristol Myers Squibb Company $BMY - Stock Observer

Barclays Names Eli Lilly (LLY) and Bristol-Myers Squibb (BMY) as Top Pharma Stocks to Buy Now | Markets Insider

Holderness Investments Co. Sells 8,222 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Huntington National Bank Sells 14,648 Shares of Bristol Myers Squibb Company $BMY - Daily Political

Big Pharma Dividend Stock BMY Could Help Turn $100,000 Into a Seven‑Figure Retirement

Is Bristol Myers Squibb (BMY) Pricing Look Attractive After Recent Share Price Climb

Quantbot Technologies LP Buys 354,309 Shares of Bristol Myers Squibb Company $BMY

Handelsbanken Fonder AB Has $50.92 Million Stake in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Purchased by DNB Asset Management AS

Wealthedge Investment Advisors LLC Purchases 15,466 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

A small-molecule inverse agonist of PPARγ for advanced solid tumors: a phase 1 trial

Is Bristol-Myers Squibb Stock Underperforming the Nasdaq?

Bristol Myers Squibb Company $BMY Shares Purchased by Banco Santander S.A.

Bristol Myers Squibb Company $BMY Shares Sold by Clifford Swan Investment Counsel LLC

MAI Capital Management Has $7.96 Million Stock Holdings in Bristol Myers Squibb Company $BMY - Daily Political

Close Asset Management Ltd Sells 9,003 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Systimmune's iza-bren hits phase III breast cancer goals in China | BioWorld

TD Asset Management Inc Trims Stake in Bristol Myers Squibb Company $BMY - Daily Political

The landscape of the intestinal microbiome among patients with newly diagnosed invasive breast cancer and ductal carcinoma in situ (DCIS)

Ipilimumab and nivolumab followed by chemoradiotherapy as bladder-sparing treatment in muscle-invasive bladder cancer: a phase 2 trial

Janux Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights | Morningstar

Is Bristol Myers Squibb (BMY) Pricing In Its 2024 Results And Product Pipeline Outlook?

Izalontamab brengitecan (Iza-bren) met its dual primary endp

Bristol Myers Squibb (NYSE:BMY) Stock Rating Upgraded by Royal Bank Of Canada

Fox Run Management L.L.C. Invests $1.18 Million in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb (NYSE:BMY) Rating Increased to Hold at Royal Bank Of Canada - Stock Observer

Primecap Management Co. CA Sells 850,330 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Bristol Myers Squibb (NYSE:BMY) Upgraded by Royal Bank Of Canada to "Hold" Rating - Daily Political

RBC Capital Initiates Bristol Myers (BMY) with $60 Target, Cites Late-Stage Pipeline Depth

Lotte Biologics Bets Drugmakers Will Shift Orders Out of China